ArticleLeukemia2012
The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients.
A M Gruszka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it